- Home
- BTAI vs TPCS Comparison
BTAI vs TPCS Comparison
Compare BTAI & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- TPCS
- Stock Information
- Founded
- BTAI 2017
- TPCS 1956
- Country
- BTAI United States
- TPCS United States
- Employees
- BTAI N/A
- TPCS N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- TPCS Metal Fabrications
- Sector
- BTAI Health Care
- TPCS Industrials
- Exchange
- BTAI Nasdaq
- TPCS Nasdaq
- Market Cap
- BTAI 52.7M
- TPCS 51.4M
- IPO Year
- BTAI 2018
- TPCS N/A
- Fundamental
- Price
- BTAI $3.79
- TPCS $5.25
- Analyst Decision
- BTAI Strong Buy
- TPCS
- Analyst Count
- BTAI 4
- TPCS 0
- Target Price
- BTAI $40.00
- TPCS N/A
- AVG Volume (30 Days)
- BTAI 14.1M
- TPCS 82.0K
- Earning Date
- BTAI 08-12-2025
- TPCS 08-21-2025
- Dividend Yield
- BTAI N/A
- TPCS N/A
- EPS Growth
- BTAI N/A
- TPCS N/A
- EPS
- BTAI N/A
- TPCS N/A
- Revenue
- BTAI $868,000.00
- TPCS $33,424,000.00
- Revenue This Year
- BTAI N/A
- TPCS N/A
- Revenue Next Year
- BTAI $597.46
- TPCS N/A
- P/E Ratio
- BTAI N/A
- TPCS N/A
- Revenue Growth
- BTAI N/A
- TPCS 3.78
- 52 Week Low
- BTAI $1.17
- TPCS $2.05
- 52 Week High
- BTAI $13.36
- TPCS $6.25
- Technical
- Relative Strength Index (RSI)
- BTAI 48.02
- TPCS 52.49
- Support Level
- BTAI $3.41
- TPCS $5.20
- Resistance Level
- BTAI $4.20
- TPCS $5.82
- Average True Range (ATR)
- BTAI 0.62
- TPCS 0.39
- MACD
- BTAI -0.27
- TPCS -0.06
- Stochastic Oscillator
- BTAI 11.05
- TPCS 40.72
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About TPCS TechPrecision Corporation Common stock
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.